Lipigon Pharmaceuticals is specialized in fat metabolism and develops new blood lipids.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Umeå
State: Vasterbottens Lan
Zip:
Country: Sweden
Lipigon Pharmaceuticals is specialized in fat metabolism and develops new blood lipids. Lipigon is currently focusing on developing drugs directed against the enzyme lipoprotein lipase (LPL). People with low activity at LPL have a higher incidence of elevated blood fats and also related disorders such as insulin resistance and metabolic syndrome. Thanks to Lipigon&s;s expertise in this area, AstraZeneca has chosen to enter into a cooperation agreement with the Company to develop LPL-based pharmaceuticals. Lipigon can receive up to $ 110 million in compensation at achieved milestones related to development and sales.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2016 | Seed Round | 2 | - |
Partnerinvest Norr Almi Invest Partnerinvest Norr Almi Invest |
2/2019 | Seed Round | 1 | $852.5k |
Sciety Sciety |
2/2019 | Seed Round | 1 | $852.5k |
Sciety Sciety |
12/2016 | Seed Round | 2 | - |
Almi Invest Partnerinvest Norr Almi Invest Partnerinvest Norr |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|